| Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease (NCT06299631) | University Hospital, Montpellier | 2015-01-01 |
| Fecal Microbial Transplant in Pediatric Crohn's Disease (NCT02272868) | Seattle Children's Hospital | 2015-01-01 |
| Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease (NCT02201693) | Assistance Publique - Hôpitaux de Paris | 2014-12-12 |
| To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC) (NCT02326155) | Celltrion | 2014-12-08 |
| Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease (NCT02255370) | University Hospital, Clermont-Ferrand | 2014-12-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease (NCT02249078) | Eisai Inc. | 2014-12-01 |
| Vagus Nerve Stimulation in Crohn's Disease (NCT02311660) | SetPoint Medical Corporation | 2014-12-01 |
| The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease (NCT02453607) | Ernest Seidman | 2014-11-17 |
| The Impact of "Crohn's Disease-TReatment-with-EATing" Diet and Exclusive Enteral Nutrition on Healthy Gut Bacteria (NCT02426567) | University of Glasgow | 2014-11-01 |
| Comparison of Endoscopy and Diffusion-weighted Enterography-MRI for the Diagnosis of Crohn's Disease Recurrence Following Ileocolic Resection: a Pilot Study (NCT02867540) | CHU de Reims | 2014-11-01 |
| One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease (NCT02240108) | Bausch Health Americas, Inc. | 2014-10-28 |
| GI Symptoms and Sleep Disturbances in Patients With Quiescent Crohns Disease (NCT02245594) | University of Aarhus | 2014-10-01 |
| The NOR-SWITCH Study (NCT02148640) | Diakonhjemmet Hospital | 2014-10-01 |
| Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease (NCT02096861) | Celltrion | 2014-09-19 |
| Brain-Gut Interactions in Crohn's Disease (NCT02108938) | University of Wisconsin, Madison | 2014-09-10 |
| Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics (NCT02316678) | University of Pennsylvania | 2014-09-01 |
| Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease (NCT02193048) | Ferring Pharmaceuticals | 2014-09-01 |
| Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD (NCT02197780) | University Medical Center Groningen | 2014-09-01 |
| A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (NCT02154425) | UCB BIOSCIENCES, Inc. | 2014-09-01 |
| Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD). (NCT02265588) | Erasmus Medical Center | 2014-09-01 |
| A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD) (NCT02130362) | AbbVie | 2014-08-28 |
| One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease (NCT02240121) | Bausch Health Americas, Inc. | 2014-08-21 |
| Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115 (NCT02185014) | AbbVie | 2014-08-12 |
| Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease. (NCT02225795) | TriStar Health | 2014-08-01 |
| Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) (NCT02000362) | Kang Stem Biotech Co., Ltd. | 2014-08-01 |
| The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients (NCT02330458) | Cedars-Sinai Medical Center | 2014-07-01 |
| Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease (NCT02199561) | University of Alberta | 2014-07-01 |
| Effect of Soluble Dietary Fiber on Bacterial Translocation in Crohn's Disease (NCT02164877) | Jinling Hospital, China | 2014-06-01 |
| Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative Colitis (NCT02213835) | David Suskind | 2014-06-01 |
| Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease (NCT02193802) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2014-05-01 |
| Impact of the Fecal Flora Transplantation on Crohn's Disease (NCT02097797) | Assistance Publique - Hôpitaux de Paris | 2014-05-01 |
| Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease (NCT02065570) | AbbVie | 2014-05-01 |
| Anti TNF α Improves Endothelial Dysfunction in IBD Patients (NCT01881464) | Carmel Medical Center | 2014-05-01 |
| Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease (NCT02148185) | Tanabe Pharma Corporation | 2014-05-01 |
| Telemedicine Crohn's Disease and Ulcerative Colitis (TECCU) (NCT02943538) | Instituto de Investigacion Sanitaria La Fe | 2014-05-01 |
| A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease (NCT02039063) | EA Pharma Co., Ltd. | 2014-04-05 |
| Evaluation of Health Costs and Resource Utilization (NCT01960426) | University of Western Ontario, Canada | 2014-04-01 |
| Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease (NCT02913508) | Takeda | 2014-04-01 |
| A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma (NCT02087878) | AbbVie | 2014-03-31 |
| Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy (NCT01698307) | Alimentiv Inc. | 2014-03-28 |
| Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis (NCT03256240) | Weill Medical College of Cornell University | 2014-03-12 |
| Evaluating a Shared Decision Making Program for Crohn's Disease (NCT02084290) | Dartmouth-Hitchcock Medical Center | 2014-03-01 |
| Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients (NCT01986127) | Sara Varea | 2014-02-14 |
| Development of 'Emma'--a Pediatric IBD Quiz (NCT02065089) | Mayo Clinic | 2014-02-06 |
| Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease (NCT02057016) | Catholic University of the Sacred Heart | 2014-02-01 |
| Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment (NCT01932658) | University of California, Los Angeles | 2014-02-01 |
| Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease (NCT02048618) | Lakefront Biotherapeutics NV | 2014-02-01 |
| Antibiotics and Hydroxychloroquine in Crohn's (NCT01783106) | Royal Liverpool University Hospital | 2014-02-01 |
| Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease (NCT02054533) | Icahn School of Medicine at Mount Sinai | 2014-02-01 |
| Single Port Colic Laparoscopic Surgery (NCT01959087) | Assistance Publique - Hôpitaux de Paris | 2014-01-27 |
| Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases (NCT01988506) | Assistance Publique - Hôpitaux de Paris | 2014-01-06 |
| T and B Cell Responses in Autoimmune Diseases (NCT01947036) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-01 |
| High Dose Vitamin D3 in Crohn's Disease (NCT02615288) | McMaster University | 2014-01-01 |
| Predictors Favoring the Role of Exclusive Enteral Nutrition in Active Crohn's Disease (NCT02942511) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2014-01-01 |
| Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease (NCT02066272) | Maria Sklodowska-Curie National Research Institute of Oncology | 2014-01-01 |
| A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta (NCT02019602) | UCB BIOSCIENCES, Inc. | 2014-01-01 |
| Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission (NCT02044952) | Zhu Weiming | 2014-01-01 |
| Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease (NCT02015793) | AbbVie | 2013-12-01 |
| Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease (NCT01891214) | Rennes University Hospital | 2013-12-01 |
| Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort (NCT02502552) | Centre Hospitalier Universitaire de Saint Etienne | 2013-11-01 |
| Food and Crohn's Exacerbation Study (FACES) (NCT01926730) | University of Pennsylvania | 2013-11-01 |
| Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn's Disease (NCT02859675) | Centre Hospitalier Universitaire Dijon | 2013-10-07 |
| Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease (NCT02826330) | University Hospital, Lille | 2013-10-03 |
| Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease (NCT03000296) | Beneficência Portuguesa de São Paulo | 2013-10-01 |
| Calprotectin-Directed Humira® Maintenance Therapy (CADHUM) (NCT01674413) | Peter Higgins | 2013-10-01 |
| The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients (NCT01916161) | National Health Service, United Kingdom | 2013-10-01 |
| Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease (NCT01860651) | Hvidovre University Hospital | 2013-09-01 |
| Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease (NCT02395354) | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 2013-09-01 |
| A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease (NCT01958827) | AbbVie | 2013-09-01 |
| Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease (NCT01951326) | RedHill Biopharma Limited | 2013-09-01 |
| L-carnitine to Treat Fatigue Associated With Crohn's Disease (NCT01523106) | University of California, San Francisco | 2013-08-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease (NCT05815355) | Sixth Affiliated Hospital, Sun Yat-sen University | 2013-07-01 |
| Self-Management Assistance for Recommended Treatment (SMART) Portal (NCT01966744) | Children's Hospital Medical Center, Cincinnati | 2013-07-01 |
| Crohn's Extent of Resection Trial (NCT01876264) | Oxford University Hospitals NHS Trust | 2013-06-01 |
| Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects (NCT01827631) | GlaxoSmithKline | 2013-05-27 |
| Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease (NCT02073526) | Oslo University Hospital | 2013-05-01 |
| Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease (NCT01860846) | AbbVie | 2013-05-01 |
| Impact of Exclusive Enteral Nutrition Therapy on Sperm Quality of Patients With Crohn's Disease (NCT02233062) | Jinling Hospital, China | 2013-05-01 |
| Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease (NCT01847170) | Beth Israel Deaconess Medical Center | 2013-05-01 |
| Autologous Stem Cell Transplant for Refractory Crohn's Disease (NCT02676622) | Nationwide Children's Hospital | 2013-04-01 |
| Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease (NCT01817972) | Gastroenterology Research of America | 2013-03-01 |
| Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease (NCT01810185) | Santa Barbara Cottage Hospital | 2013-03-01 |
| Combined THC and CBD Drops for Treatment of Crohn's Disease (NCT01826188) | Meir Medical Center | 2013-03-01 |
| Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease (NCT01809275) | Qu Biologics Inc. | 2013-03-01 |
| The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers (NCT01828190) | Assaf-Harofeh Medical Center | 2013-03-01 |
| Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice (NCT01768858) | AbbVie | 2013-02-05 |
| The Effect of Vitamin D3 to Maintain Surgical Remission in Postoperative Crohn's Disease (NCT02010762) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2013-02-01 |
| Cimzia Versus Mesalamine for Crohn's Recurrence (NCT01696942) | Milton S. Hershey Medical Center | 2013-02-01 |
| Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease. (NCT01714726) | AstraZeneca | 2013-02-01 |
| Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure (NCT01802593) | Prof. Arie Levine | 2013-02-01 |
| A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease (NCT01751152) | Novo Nordisk A/S | 2013-02-01 |
| Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders (NCT01540292) | University of Liege | 2013-02-01 |
| Development of Niv Score of Capsule Endoscopy in Patients With Crohn's (CECDAIic) (NCT01793376) | Medtronic - MITG | 2013-02-01 |
| The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) (NCT01765998) | The Baruch Padeh Medical Center, Poriya | 2013-02-01 |
| The ImageKids Study: Developing the pMEDIC and the PICMI (NCT01881490) | Shaare Zedek Medical Center | 2013-01-01 |
| Infliximab Top-down in Pediatric Crohn (NCT01880307) | Erasmus Medical Center | 2013-01-01 |
| An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR) (NCT01759264) | AbbVie (prior sponsor, Abbott) | 2013-01-01 |
| Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease (NCT01728870) | Prof. Arie Levine | 2013-01-01 |
| Thalidomide in Treating Crohn's Disease (NCT02501291) | First Affiliated Hospital, Sun Yat-Sen University | 2013-01-01 |